Webinar | Tuesday, October 7, 2025

Development of a Low-dose Percutaneous Delivery System for Lenalidomide in Hematologic Malignancies: From Ideation to Phase 2
Discover how Starton Therapeutics advanced their innovation journey—leveraging iPRECIO^® Programmable Pumps in proof-of-concept in-vivo studies—to transform early research into clinical success.

>> Register and details

Congratulations Arialys Therapeutics on your new peer-reviewed data published in Nature Communications demonstrating the potential of your lead candidate, ART5803, to address anti-NMDA receptor encephalitis and related autoimmune neuropsychiatric diseases. First time for us to see our SMP-200 pumps used for disease induction and disease treatment in a peer reviewed publication.

Kanno, A., Kito, T., Maeda, M. et al. Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis. Nat Commun 16, 5292 (2025). https://doi.org/10.1038/s41467-025-60628-1

Latest references updated. For our latest iPRECIO Applications Examples and Tabular highlights, contact us by e-mail to iprecio@primetech.co.jp or through our contact form. https://www.iprecio.com/contact/form/tabid/231/Default.aspx

Important News – Incompatible Analgesic containing MCT Oil

We have found that Ethiqa XR long acting analgesia which contains MCT oil is not compatible with iPRECIO pumps. The use of Ethiqa XR as analgesic has been found to weaken iPRECIO pump reservoir and cause leaks. More significant damage has also occurred. We recommend not to use Ethiqa XR or any analgesic formulations containing oils. If the use of Ethiqa XR is important, please contact Primetech Corporation for further information.

Finally, as a reminder, iPRECIO Pumps are not compatible with oils as vehicle and oils will weaken and will destroy the reservoir and catheter.

Christian Schnell's (Novartis Oncology) talk on "Challenges in enabling translation of tumor models in cancer therapy: Exploiting secreted luciferases to monitor tumor metastasis as a promising approach" at the Swiss 3Rs Day 2024 in the AGORA Cancer Research Centre in Lausanne. Recording sponsored by Primetech Corporation – makers of iPRECIO^® Programmable Pumps.

https://www.youtube.com/watch?v=7Tcdb4L3gCY